Background Ascorbic acid (AA) is required for normal human health and development. Human intestine expresses two sodium-dependent vitamin C transporters (hSVCT-1 and -2) that mediate cellular AA transport, with hSVCT1 targeting to the apical membrane of polarized epithelia. Studies have shown a role for the Rab8a in the apical membrane targeting of transporters in intestinal cells. Aims The purpose of this study was to determine whether Rab8a impacts the function and/or targeting of hSVCT1, and intestinal AA uptake. Methods We used human intestinal cells and cells from a Rab8a knockout mouse.
Introduction
Vitamin C (Ascorbic acid, AA) is an essential water-soluble micronutrient that is required for normal cellular function, growth, and development. Vitamin C deficiency leads to a variety of abnormalities including scurvy, delayed wound healing, bone and connective tissue damage, and vasomotor instability [1] . Optimal vitamin C body homeostasis has been reported to have a protective effect against gall bladder disease, cardiovascular disease, cancer, and cataract formation [2] [3] [4] .
Humans have lost the capability of synthesizing vitamin C and therefore obtain the vitamin from dietary sources. Significant progress has been made in understanding the molecular basis of vitamin C absorption across intestinal epithelia, a process which involves two sodium-dependent vitamin C transporters (hSVCT1 and hSVCT2). hSVCT1 is expressed at the apical surface, and hSVCT2 at the basolateral surface of polarized enterocytes, distributions suggestive of a route for vectorial transport of vitamin C from the gut to the bloodstream [5] [6] [7] [8] . Less well understood are aspects of the cell biology of these transporters; for example, the cellular determinants that control membrane targeting and intracellular trafficking in intestinal epithelia.
Recent studies have shown that specific Rab proteins regulate the localization, trafficking, and function of membrane proteins in intestinal epithelial cells [9] [10] [11] . Notably, Rab8 has been shown to be necessary for the apical localization of a number of proteins in enterocytes [10, 11] . However, nothing is known about whether the function of this small GTPase impacts hSVCT1 functionality, or its functional impact extends to only a subset of apically targeted transporters. Therefore, we used humanderived cultured intestinal epithelial cell lines and tissue from a conditional, intestine-specific Rab8a knockout (KO) mouse model to investigate the role of Rab8a in hSVCT1 cell biology and physiology. Our results demonstrate that in vitro knockdown or in vivo ablation of Rab8a impairs AA uptake. In both model systems, this effect correlated with decreased levels of hSVCT1 protein, but not mRNA levels. Our results support a model where (1) Rab8a is required for apical plasma membrane targeting of hSVCT1, and (2) lysosomal accumulation and degradation of this transporter occurs in the absence of the Rab8a-sensitive cell surface trafficking pathway.
Methods

Materials [
14 C]-AA (specific activity *13 mCi/mmol) was from American Radiolabeled Chemical (ARC, St. Louis, MO, USA). YFP-N1 and DsRed-C1 fluorescent proteins were from Clontech (Palo Alto, CA, USA). LAMP1-RFP was obtained from Addgene Inc (Cambridge, MA, USA). Caco-2, HuTu-80, and HT-29 cells were from ATCC (Manassas, VA, USA) and NCM460 cells were from Incell (San Antonio, TX, USA) [12] . DNA oligonucleotide primers were synthesized by Sigma Genosys (Woodlands, TX, USA).
Generation of hSVCT1 and Rab8a Fusion Constructs
The full-length hSVCT1-YFP construct was as used previously. The DsRed-Rab8a (Dr. David R. Sheff, University of Iowa, IA, USA, generously provided GFP-Rab8a plasmid) construct was generated by PCR using the primer combinations shown in Table 1 and conditions as described before [8] . The Rab8a PCR products and the DsRed-C1 vector were digested with SalI and Bam HI, and products were gel-separated and ligated to generate in-frame fusion proteins with the red fluorescent protein (DsRed-C1) fused to the NH 2 -terminus of Rab8a full-length protein. The nucleotide sequence of the construct was verified by sequencing (Laragen, CA, USA).
Cell Culture, Transient Transfection, and Uptake Assay
The human-derived intestinal epithelial Caco-2 and HuTu-80 cells were grown in MEM (ATCC, Manassas, VA, USA), HT-29 cells were grown in McCoy's medium (Sigma) and NCM460 cells were grown in Ham's F-12 medium (Invitrogen) supplemented with 10 % (v/v) fetal bovine serum (FBS), glutamine (0.29 g/l), sodium bicarbonate (2.2 g/l), penicillin (100,000 U/l), and streptomycin (10 mg/l) in 75-cm 2 plastic flasks at 37°C in a 5 % CO 2 -95 % air atmosphere with media changes every 2-3 days. For imaging studies, cells were grown on sterile glass-bottomed petri-dishes (MatTek, MA, USA) and transfected at 90 % confluency with 2-4 lg plasmid DNA using Lipofectamine 2000 (Invitrogen, CA, USA). After 48 h, live cells were imaged using confocal microscopy. For uptake, mRNA, and western blot analysis, Caco-2 cells were grown on 12-well plates (Corning, NY, USA) and Rab8a siRNA [pool of three different siRNA duplexes (duplex-1, sense: GAACUGGAUUCGCAACAU Utt, antisense: AAUGUUGCGAAUCCAGUUCtt; duplex-2, sense: GAACAAGUGUGAUGUGAAUtt, antisense: AUUC ACAUCACACUUGUUCtt; duplex-3, sense: CCAGAAUGC AAUUGAGAAAtt, antisense: UUUCUCAAUUGCAUUC UGGtt); specific for human Rab8a (Santa Cruz, CA, USA)] was transfected at 80 % confluence. Studies were performed after 48 h of transfection. [ 14 C]-AA uptake assays were performed on transfected Caco-2 cells following established procedures [13] . Protein contents were estimated on parallel wells using a protein assay kit (Bio-Rad, CA, USA).
Ascorbic Acid Uptake Assay in Rab8a Knockout (KO) Mice Small intestine-specific Rab8a KO mice [11] were housed at the Long Beach VA Medical Center facility. The animal use committee of Long Beach VA Medical Center approved the experimental protocols. To determine the AA uptake in small intestinal tissue, Rab8a KO and wild-type (litter-mate) mice were euthanized and the jejunum portion of small intestinal segments were incubated in Kreb's Ringer's buffer containing 14 C-AA (32 lM) at pH 7.4 for 5 min as described [14, 15] . Total protein for each sample was measured using a protein assay kit (Bio-Rad). A portion of scraped small intestinal mucosa was stored in RIPA buffer (Sigma) for protein isolation and a portion of small intestine was stored in Trizol (Invitrogen) for RNA isolation.
Real-Time PCR
Total RNA was isolated from Caco-2 cells or whole mouse small intestine. Conditions used for the real-time PCR to determine the level of SVCT1, -2, Rab8a and b-actin mRNA were as described previously [16] . The data were normalized to b-actin and then quantified using a relative relationship method as described previously [17] . Genespecific primers are listed in Table 1 .
Western Blot Analysis
Western blot analysis was performed on cellular extracts prepared from control and Rab8a siRNAs-treated Caco-2 cells or on Rab8a KO mice and wild-type (litter-mate) intestinal mucosal scrapping using established procedures [18] . Proteins (60 lg) were resolved onto 4-12 % Bis-Tris mini-gel (Invitrogen) as described [18] . After electrophoresis, proteins were electroblotted onto polyvinylidene fluoride membrane (LI-COR, Lincoln, NB, USA) and blocked with a LI-COR blocking buffer (LI-COR) for 1 h at room temperature (RT). Membranes were then incubated with either anti-rabbit hSVCT1/mSVCT1 (Santa Cruz) or human Rab8a (Sigma)/mouse Rab8a (Santa Cruz) along with mouse monoclonal b-actin antibodies (Santa Cruz). Immunodetection was performed by incubating the membrane with secondary antibodies [IRDye 800 labeled goat anti-rabbit or IRDye 680 labeled goat anti-mouse (1:30,000 dilutions for both secondary antibodies); LI-COR] for 45 min at RT. Signals were detected and quantified with the Odyssey Infrared Imaging Systems (LI-COR) and accompanying LI-COR software (LI-COR).
Cell Surface Biotinylation
Control and Rab8a siRNAs (Santa Cruz) were transiently transfected into Caco-2 cells (90 % confluent). Samples were biotinylated after 48 h of transfection using an EZ-Link Sulfo-NHS-Biotinylation Kit (Thermo Fisher Scientific, Rockford, IL, USA) and then lysed according to the manufacturer's instructions. An equal concentration of total soluble protein from Rab8a or control siRNAs-treated cells was then incubated with avidin-conjugated agarose. The biotinylated protein bound to the agarose-avidin beads was washed three times and eluted in NuPAGE LDS sample loading dye (Invitrogen) and subjected to western blot analysis in a NuPAGE 4-12 % Bis-Tris gradient minigel (Invitrogen). For normalization, an equal protein concentration of total cell lysate was loaded simultaneously and the level of surface expression of hSVCT1 was determined using specific hSVCT1 antibody followed by IRDye 800 labeled goat anti-rabbit (1:30,000) secondary antibody. Signals were detected and quantified as described above using the Odyssey Infrared Imaging Systems (LI-COR).
Live Cell Confocal Imaging
Cells cultured on Petri dishes were imaged using a Nikon C-1 confocal scanner head attached to a Nikon inverted phase-contrast microscope. Fluorophores were excited using the 488 nm/543 nm line from an argon/HeNe ionlaser, and emitted fluorescence was monitored with a 515 ± 30-nm short band pass filter (YFP) and 570 ± 50-nm long pass filter (DsRed).
Statistical Analysis
Uptake data are presented as mean ± SE from multiple different experiments and are expressed in percentage [5, 8, 19] at the cell surface and within intracellular vesicular compartments, while DsRed-Rab8a was found to be expressed throughout the cytoplasm in each intestinal cell line examined (Fig. 1) .
The overlapped confocal images of the Caco-2, HT-29, NCM460, and HuTu-80 cells showed strong co-localization of the two constructs in vesicular structures that were located throughout the cytoplasm (Fig. 1) .
Effect of Knockdown and Knockout (KO) of Rab8a
Gene on AA Uptake In Vitro and In Vivo Systems
Our aim in these experiments was to examine the effect of selective knockdown of endogenous Rab8a on 14 C-AA uptake. First, we examined the effect of silencing endogenous Rab8a on 14 C-AA (32 lM) uptake by Caco-2 cells transiently expressing hSVCT1; data were compared to uptake by control (scrambled siRNA-treated) hSVCT1 expressing Caco-2 cells. The results showed a significant (p \ 0.02) inhibition in AA uptake by Rab8a siRNAtreated hSVCT1 expressing cells compared to control cells (Fig. 2a) . We also examined the effect of Rab8a siRNAtreatment on uptake of AA by untransfected Caco-2 cells, i.e., examined the effect of Rab8a siRNA treatment on endogenous AA uptake. The results again showed a significant (p \ 0.03) inhibition in AA uptake when compared to control (data not shown). To verify that Rab8a mRNA expression level was reduced in these assays, we assessed mRNA and protein levels in the Caco-2 samples. Treating Caco-2 cells with Rab8a siRNA significantly (p \ 0.01) decreased the Rab8a mRNA expression level compared to control siRNA-treated Caco-2 cells (Fig. 2b) . Finally, western blot analysis with human Rab8a-specific antibodies showed that the Rab8a protein expression level was also significantly (p \ 0.01) decreased compared to control siRNA-treated Caco-2 cells (Fig. 2c) .
To complement the results of the in vitro studies, we used Rab8a KO mice previously generated by Sato et al. [11] as an in vivo model system. Results showed significant (p \ 0.01) inhibition in carrier-mediated AA uptake in the jejunum of Rab8a KO mice compared to uptake in the jejunum of their wild-type litter-mate (Fig. 2d) . Rab8a mRNA expression was severely (p \ 0.01) ablated in Rab8a KO mice compared to control litter-mates (Fig. 2e) , [with the residual expression being explained by co-isolation of non-intestinal cells from the tissue (intestinal)-specific KO animals]. As expected, western blot analysis of mucosal scrapping showed that the Rab8a protein expression was absent in Rab8a KO mice compared to their wild-type littermates (Fig. 2f) .
Effect of Rab8a Impairment on SVCT1 mRNA and Protein Expression Levels Next, we examined hSVCT1 (and hSVCT2) mRNA expression levels after treatment with gene specific Rab8a siRNA. Results showed no significant change in hSVCT1 (or hSVCT2) mRNA expression levels in Rab8a siRNAtreated cells compared to control siRNA-treated cells (Fig. 3a) . We also compared hSVCT1 protein expression in Rab8a siRNA-treated Caco-2 cells as compared to control cells by western blot analysis. Results showed that the hSVCT1 (Fig. 3b) protein expression level was significantly (p \ 0.01) decreased in Rab8a siRNA-treated cells compared to control cells. Similarly, in Rab8a KO mice, mRNA levels for mSVCT1 (and mSVCT2) were similar to those in wild-type litter-mates (Fig. 3c) . However, mSVCT1 protein expression level was significantly (p \ 0.02) reduced in Rab8a KO mice jejunal mucosa compared to levels observed with wild-type litter-mates (Fig. 3d) .
Effect of Silencing Rab8a on Cell Surface Expression of hSVCT1 in Caco-2 Cells
To understand the reasons for the observed inhibition in AA uptake after Rab8a siRNA-treatment of Caco-2 cells, the cell surface expression levels of the hSVCT1 protein were examined. To do this, we compared biotinylation of cell surface proteins in Rab8a siRNA-treated with control cells, having normalized the cell surface expression level of hSVCT1 with total cellular hSVCT1 protein in the same samples. The cell surface expression of hSVCT1 was significantly (p \ 0.01) decreased in Rab8a siRNA-treated cells compared with cells treated with control siRNA (Fig. 4) .
Effect of Silencing Rab8a Gene on hSVCT1 Trafficking
Finally, human-derived intestinal epithelial HuTu-80 cells were co-transfected with hSVCT1-YFP, LAMP1-RFP (a lysosomal marker), and control or Rab8a siRNAs. Live cell imaging was performed 48 h after transfection. Results showed that hSVCT1 was expressed at the cell membrane in control cells, whereas cell surface expression was less evident in Rab8a siRNA-treated cells. In Rab8a siRNAtreated cells, there was significant overlap between hSVCT1-YFP and LAMP1-RFP (Fig. 5) . These results
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Discussion
Recent studies have shown the importance of Rab8a in apical localization of several brush border membrane proteins in polarized intestinal epithelial cells [10, 11] . Specifically, dipeptidyl peptidease IV, alkaline phosphatase, sucrose-isomaltase, and the oligopeptide transporter 1 showed impaired localization at the brush border membrane domains of intestinal epithelial cells of Rab8 KO mice [11] . These markers were found to be mislocalized to late endosomes/lysosomes, where the proteins were degraded. Phenotypically, this impairment in polarized targeting of important proteins led to a reduction in various nutrient digestion and absorption in the small intestine (shortened microvilli), that resulted in malnutrition and death of the KO mice [11] . This outcome parallels what is believed to be happening in the clinical condition known as microvillus inclusion disease [20, 21] . Does the role of Rab8 extend to regulation of the targeting of multivitamin transporters within the solute carrier (SLC) family? To investigate this issue, we tested whether hSVCT1, the apically localized vitamin C transporter also displays Rab8-dependent trafficking in a number of wellestablished human-derived intestinal epithelial cell models and native small intestine of intestinal-specific Rab8a KO mice. These preparations represented in vitro and in vivo experimental model systems for investigating the role of Rab8a in AA transport physiology, respectively. Coexpression studies revealed that there was significant overlap between hSVCT1 and Rab8a proteins in vesicular structures within the intestinal epithelial cell lines in vitro. Further, we found that knockdown of the endogenous Rab8a in Caco-2 cells resulted in a significant inhibition in AA uptake. This functional impairment in AA uptake appeared to be the result of the marked reduction in C-AA uptake (32 lM) by Rab8a KO mice jejunal portion was performed as described in ''Methods''. Values are mean ± SE of at least three separate uptake determinations from multiple sets of mice. *p \ 0.01. e Real-time PCR was performed on total RNA isolated from Rab8a KO and wild-type (litter-mate) mice jejunal mucosa using mouse Rab8a and b-actin gene-specific primers. Data are mean ± SE of at least three separate samples from three different mice. *p \ 0.01. f (Top) western blot analysis was performed on Rab8a KO (right) and wild-type litter-mate (left) mouse jejunum mucosal (60 lg) proteins. Blots were incubated with rabbit polyclonal anti-mouse Rab8a antibodies along with b-actin antibodies. Bottom densitometric values. Data are mean ± SE of at least three sets of samples from three different mice expression of the hSVCT1 protein at the cell surface of the Rab8a siRNA-treated cells. On the other hand, no change in the level of expression of hSVCT1 mRNA was observed in Rab8a siRNA-treated Caco-2 cells compared to control cells. In agreement with these observations, we found a significant inhibition in AA uptake in the jejunal portion of Rab8a KO mice compared to their control litter-mate animals. Again, this functional impairment was associated with a marked reduction in the level of mSVCT1 protein expression at the cell membrane in the Rab8a KO mice compared to wild-type litter-mates with no change in the expression level of mSVCT1 (and mSVCT2) mRNA. One possible explanation for the reduction in cell surface expression of the SVCT1 protein in both of the abovedescribed systems is that the SVCT1 protein is degraded following mis-targeting to lysosomes, as suggested previously [11] . To assess this possibility, we co-transfected with hSVCT1-YFP, LAMP1-RFP, and control or Rab8a siRNAs in intestinal epithelial cells. The endogenous Rab8a knockdown in these cells yielded significant overlap between hSVCT1-YFP and LAMP1-RFP. Therefore, our findings agree with the previously proposed explanation [11] that enhanced lysosomal degradation of hSVCT1 may follow impairment of Rab8a function, and extends previous findings that Rab8a supports the proper localization of a broad swathe of apical proteins in the intestine. 
